AMZN
Amazon.com, Inc.
AMZN has the edge over XPEL overall, supported by lower modeled downside and stronger modeled upside.
XPEL
XPEL, Inc.
XPEL offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
XPEL Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Under pressure | |
| Strong |
XPEL's revenue, profitability and balance sheet are currently healthy, but its cash flow is under pressure.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over XPEL in the historical PE scenario, which offers more potential upside but is not a forecast.
XPEL PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 16x | $37.62 | — |
| Current | 18x | $37.62 | — |
| Cheap | 22x | $46.19 | +23% |
| Fair | 33x | $68.12 | +81% |
| Expensive | 58x | $121 | +222% |
Historical ranges are pointers, not guarantees.
XPEL's PE is in its cheap range at 18x. If earnings grow as analysts expect, today's price would be 16x next year's earnings.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
XPEL Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
XPEL has the edge over AMZN on the outlook, with more favorable valuation expectations.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over XPEL on earnings, with more consistent year-over-year improvement.
XPEL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.33 | +11% |
| Q3 2026 | $2.09 | +23% |
| Q2 2026 | $1.97 | +11% |
| Q1 2026 | $1.91 | +11% |
| Q4 2025 | $1.85 | +12% |
| Q3 2025 | $1.70 | -3.4% |
| Q2 2025 | $1.77 | +3.5% |
| Q1 2025 | $1.72 | -1.1% |
| Q4 2024 | $1.65 | -14% |
XPEL earned $2.09 per share over the past year, up 23% from the year before.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over XPEL on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN's operating margin was 14% last quarter, up 4.2 points from the same quarter a year ago, near the top of its range since 2019.
XPEL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $137.8M | +9.9% |
| Q2 2026 | $143.1M | +15% |
| Q1 2026 | $117.4M | +13% |
| Q4 2025 | $122.3M | +14% |
| Q3 2025 | $125.4M | +11% |
| Q2 2025 | $124.7M | +13% |
| Q1 2025 | $103.8M | +15% |
| Q4 2024 | $107.5M | +1.9% |
XPEL's revenue has grown year over year every quarter since late 2020: $138M last quarter, up 9.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 15% | +1.9 points |
| Q2 2026 | 16% | +0.8 points |
| Q1 2026 | 11% | +0.4 points |
| Q4 2025 | 13% | +1.2 points |
| Q3 2025 | 13% | -2.9 points |
| Q2 2025 | 15% | -2 points |
| Q1 2025 | 11% | +0.5 points |
| Q4 2024 | 11% | -2 points |
XPEL has the edge over AMZN on profitability, with a higher operating margin.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
XPEL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $19.2M | -40% |
| Q2 2026 | -$34.3M | -227% |
| Q1 2026 | -$2.3M | -205% |
| Q4 2025 | $1.6M | -66% |
| Q3 2025 | $32.2M | +76% |
| Q2 2025 | $26.9M | +7.4% |
| Q1 2025 | $2.2M | +$9.2M |
| Q4 2024 | $4.7M | +$7.4M |
XPEL has the edge over AMZN on cash flow, with more consistent year-over-year improvement.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
XPEL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -5K shares |
| 1 year | -0.2% | -63K shares |
| 3 years | 0% | -6K shares |
| 5 years | +0.1% | +24.9K shares |
| Available history | +0.1% | +25.4K shares |
XPEL has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3M |
| Q2 2026 | — |
| Q1 2026 | $2.9M |
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
XPEL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.0x | Net Cash |
| Q2 2026 | 0.1x | Very low |
| Q1 2026 | -0.6x | Net Cash |
| Q4 2025 | -0.7x | Net Cash |
| Q3 2025 | -0.9x | Net Cash |
| Q2 2025 | -0.7x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | -0.3x | Net Cash |
XPEL has the edge over AMZN on leverage, with a lower net debt burden relative to earnings.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
XPEL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.9 | Neutral |
| Stochastic | 13.9 | Oversold |
XPEL's weekly RSI is 37 (neutral) and its Stochastic is 14 (oversold).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
XPEL PE vs Consumer Cyclical Sector
| Metric | XPEL | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 18x | 0.1% below |
| PE % | 1 | 47 | 46 pts below |
XPEL has the edge over AMZN on valuation relative to its sector.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over XPEL on trend strength, trading above more of its moving averages.
XPEL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $42.7 | 12% below |
| 20 week MA | $45.5 | 17% below |
| 50 week MA | $46.5 | 19% below |
| 100 week MA | $41.2 | 8.7% below |
| 200 week MA | $49.2 | 24% below |
XPEL is in a downtrend: it's below all five of its weekly moving averages, and 24% below its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over XPEL on returns for 2026, with the stronger performance.
XPEL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $14.6 | $51.5 | +252% |
| 2021 | $51.5 | $68.5 | +33% |
| 2022 | $68.5 | $59.1 | -14% |
| 2023 | $59.1 | $53.9 | -8.9% |
| 2024 | $53.9 | $39.7 | -26% |
| 2025 | $39.7 | $52.1 | +31% |
| 2026 YTD | $52.1 | $37.6 | -28% |
XPEL has finished lower in three of the last six years. It's down 28% so far in 2026.